Microbiome Guided Precision Pharmacology in Pregnancy: Organ Crosstalk, Maternal–Fetal Drug Disposition, and PBPK ‐Informed Dosing

View at publisher Summarise with VIRAT
Authors: Nila Ganamurali, Mohanapriya Devarajan, Sarvesh Sabarathinam
Cited by: 0
References: 56

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Drug therapy during pregnancy poses unique challenges, requiring a balance between maternal benefit and fetal safety. Profound physiological changes, including altered plasma volume, protein binding, hepatic metabolism, renal clearance, and placental transfer, transform pregnancy pharmacology into a dynamic process. Classical concepts such as initiation, loading, maintenance, tapering, and therapeutic monitoring remain fundamental but demand gestation-specific adaptations. This overview integrates fundamental pharmacological concepts with clinical practices tailored for pregnancy, such as personalized dosing, therapeutic monitoring, and structured tapering. Recent studies further underscore the role of the maternal gut microbiome in shaping drug metabolism, absorption, and overall exposure. Variations in how individuals respond to medication during pregnancy may stem from microbial enzymes and metabolites that interact with the body's pharmacokinetic processes. By merging microbiome data with physiologically based pharmacokinetic modeling and pharmacometric tools, clinicians can enhance drug disposition forecasts and refine precision dosing strategies in obstetric care.

Fields of Study & Subjects

Pregnancy and Medication Impact Pharmacogenetics and Drug Metabolism Pharmaceutical studies and practices

Publication details

Journal / source
Comprehensive physiology
Volume
16
Issue
2
Pages
e70138–e70138
Publication date
27 March 2026
Language
EN